Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mareike Alter

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Parameters predicting prognosis in melanoma sentinel nodesImke Satzger, Andre Meier, Mareike Alter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Which parameters to choose for prediction of non-sentinel lymph node positivity in melanoma?Imke Satzger, Andre Meier, Mareike Alter, et al.
The Lancet. Infectious Diseases|May 25, 2019
Cutaneous and pulmonary botryomycosisSophia Bender-Saebelkampf, Ingolf Franke, Mareike Alter, et al.
Zeitschrift Fur Rheumatologie|February 24, 2026
[Inflammatory dermatosis in adult chronic non-bacterial osteomyelitis (adult CNO) from a dermatological perspective]Mareike Alter, Cornelia S L Müller, Claudia Pfoehler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 13, 2014
Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipientsMareike Alter, Imke Satzger, Harald Schrem, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 21, 2010
The hand-foot-syndrome associated with medical tumor therapy - classification and managementAnnette Degen, Mareike Alter, Florian Schenck, et al.
Dermatologie (Heidelberg, Germany)|August 14, 2024
[Sarcopenia and immune-related toxicity in patients with malignant melanoma undergoing immune checkpoint inhibition]Christian Holtorf, Miriam Mengoni, Thomas Tüting, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 18, 2021
Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysisAlexey Surov, Maciej Pech, Daniel Gessner, et al.
Cancers|October 14, 2022
Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future PerspectivesMarkus V Heppt, Christoffer Gebhardt, Jessica C Hassel, et al.
Nutrition and Cancer|September 22, 2024
The Prevalence of Sarcopenia in Patients with Solid Tumors Differs Across Regions: A Systematic ReviewMaximilian Thormann, Hans-Jonas Meyer, Andreas Wienke, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Parameters predicting prognosis in melanoma sentinel nodesImke Satzger, Andre Meier, Mareike Alter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Which parameters to choose for prediction of non-sentinel lymph node positivity in melanoma?Imke Satzger, Andre Meier, Mareike Alter, et al.
The Lancet. Infectious Diseases|May 25, 2019
Cutaneous and pulmonary botryomycosisSophia Bender-Saebelkampf, Ingolf Franke, Mareike Alter, et al.
Zeitschrift Fur Rheumatologie|February 24, 2026
[Inflammatory dermatosis in adult chronic non-bacterial osteomyelitis (adult CNO) from a dermatological perspective]Mareike Alter, Cornelia S L Müller, Claudia Pfoehler, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 13, 2014
Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipientsMareike Alter, Imke Satzger, Harald Schrem, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 21, 2010
The hand-foot-syndrome associated with medical tumor therapy - classification and managementAnnette Degen, Mareike Alter, Florian Schenck, et al.
Dermatologie (Heidelberg, Germany)|August 14, 2024
[Sarcopenia and immune-related toxicity in patients with malignant melanoma undergoing immune checkpoint inhibition]Christian Holtorf, Miriam Mengoni, Thomas Tüting, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 18, 2021
Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysisAlexey Surov, Maciej Pech, Daniel Gessner, et al.
Cancers|October 14, 2022
Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future PerspectivesMarkus V Heppt, Christoffer Gebhardt, Jessica C Hassel, et al.
Nutrition and Cancer|September 22, 2024
The Prevalence of Sarcopenia in Patients with Solid Tumors Differs Across Regions: A Systematic ReviewMaximilian Thormann, Hans-Jonas Meyer, Andreas Wienke, et al.
Pageof 3